- Home
- MGPI vs TNGX Comparison
MGPI vs TNGX Comparison
Compare MGPI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- TNGX
- Stock Information
- Founded
- MGPI 1941
- TNGX 2014
- Country
- MGPI United States
- TNGX United States
- Employees
- MGPI N/A
- TNGX N/A
- Industry
- MGPI Beverages (Production/Distribution)
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- TNGX Health Care
- Exchange
- MGPI Nasdaq
- TNGX Nasdaq
- Market Cap
- MGPI 626.9M
- TNGX 351.2M
- IPO Year
- MGPI 1988
- TNGX N/A
- Fundamental
- Price
- MGPI $31.18
- TNGX $6.01
- Analyst Decision
- MGPI Strong Buy
- TNGX Strong Buy
- Analyst Count
- MGPI 5
- TNGX 6
- Target Price
- MGPI $45.40
- TNGX $12.20
- AVG Volume (30 Days)
- MGPI 272.4K
- TNGX 2.7M
- Earning Date
- MGPI 07-31-2025
- TNGX 08-06-2025
- Dividend Yield
- MGPI 1.54%
- TNGX N/A
- EPS Growth
- MGPI N/A
- TNGX N/A
- EPS
- MGPI 0.50
- TNGX N/A
- Revenue
- MGPI $654,715,000.00
- TNGX $40,990,000.00
- Revenue This Year
- MGPI N/A
- TNGX N/A
- Revenue Next Year
- MGPI N/A
- TNGX N/A
- P/E Ratio
- MGPI $62.22
- TNGX N/A
- Revenue Growth
- MGPI N/A
- TNGX 10.09
- 52 Week Low
- MGPI $25.12
- TNGX $1.03
- 52 Week High
- MGPI $92.52
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- MGPI 53.11
- TNGX 76.36
- Support Level
- MGPI $30.64
- TNGX $5.34
- Resistance Level
- MGPI $33.38
- TNGX $6.40
- Average True Range (ATR)
- MGPI 1.13
- TNGX 0.50
- MACD
- MGPI 0.11
- TNGX -0.02
- Stochastic Oscillator
- MGPI 51.00
- TNGX 84.08
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.